𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M

✍ Scribed by Gopal Krishna; William F. Hodnick; Wengsheng Lang; Xu Lin; Srinivasa Karra; John Mao; Bijan Almassian

Book ID
111767027
Publisher
Springer US
Year
2001
Tongue
English
Weight
277 KB
Volume
2
Category
Article
ISSN
1530-9932

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of cloretazine (VNP40101M) on acu
Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin
✍ Karen L. Morris; Julie A. Adams; John A. Liu Yin πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 612 KB

We have investigated the effect of cloretazine (VNP40101M or Laromustine), a novel sulfonylhydrazine alkylating agent with significant antileukaemic activity, alone, or combined with cytarabine or daunorubicin, on the proliferation, viability and apoptosis of cell lines and acute myeloid leukaemia b